Page results
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This Mobile Health Clinic has been extensively refurbished and fitted with a new digital portable x-ray camera and modern technologies to speed patient diagnoses and treatment of infectious diseases that will be powered on green energy.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
-
Whilst the UCLH paediatric emergency department remains on divert, access for GPs to paediatrics remains available as usual.
-
Sustainability in healthcare was top of the agenda on Tuesday when the Department of Health and Social Care selected UCLH as the site to launch a new programme to reduce the reliance on single-use items in the UK health system.
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
-
UCLH has retendered and awarded five-year contracts to two companies to provide estates and facilities services across UCLH.
